Search Filters
Specialties
Regenerative Medicine
Specialties
Shoulder
Clear All
Search
Specialties
Regenerative Medicine
Specialties
Shoulder
57 results found in 2ms
What the ChondroFiller evidence actually shows
avatar
Miss Sophie Harris
24/6/2026
What the ChondroFiller evidence actually shows
ChondroFiller, a collagen scaffold, increaseskneefunction scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.ChondroFiller, a collagen scaffold, increases knee function scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.
How strong is ChondroFiller's clinical evidence
avatar
Miss Sophie Harris
12/6/2026
How strong is ChondroFiller's clinical evidence
ChondroFiller produces clinically meaningful functional improvement of approximately 30 IKDC points inkneepatients, sustained at three-year follow-up, but published evidence extends no further, leaving long-term durability unproven.ChondroFiller produces clinically meaningful functional improvement of approximately 30 IKDC points in knee patients, sustained at three-year follow-up, but published evidence extends no further, leaving long-term durability unproven.
Questions to ask before a ChondroFiller injection
avatar
Miss Sophie Harris
24/8/2026
Questions to ask before a ChondroFiller injection
ChondroFiller is a Type I collagen hydrogel injected into the joint where it recruits the patient's own progenitor cells to repair cartilage over months rather than days. Specific suitability criteria apply; questions a patient asks beforehand substantially influence whether expectations align with realistic outcomes.ChondroFiller is a Type I collagen hydrogel injected into the joint where it recruits the patient's own progenitor cells to repair cartilage over months rather than days. Specific suitability criteria apply; questions a patient asks beforehand substantially influence whether expectations align with realistic outcomes.
ChondroFiller repeat injections and long-term repair
avatar
Miss Sophie Harris
23/8/2026
ChondroFiller repeat injections and long-term repair
ChondroFiller recruits the patient's progenitor cells into a collagen scaffold that degrades over 12–18 months whilst repair tissue develops; 81% of hip patients achieved good or excellent outcomes at three to five years, but success depends heavily on whether osteoarthritis is early-stage or advanced.ChondroFiller recruits the patient's progenitor cells into a collagen scaffold that degrades over 12–18 months whilst repair tissue develops; 81% of hip patients achieved good or excellent outcomes at three to five years, but success depends heavily on whether osteoarthritis is early-stage or advanced.
ChondroFiller Injection Evidence Patients Should Weigh
avatar
Miss Sophie Harris
15/8/2026
ChondroFiller Injection Evidence Patients Should Weigh
Injected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.Injected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.
ChondroFiller™ durability compared with Arthrosamid
avatar
Miss Sophie Harris
12/8/2026
ChondroFiller™ durability compared with Arthrosamid
ChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.ChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.
Who qualifies for ChondroFiller injection
avatar
Miss Sophie Harris
11/8/2026
Who qualifies for ChondroFiller injection
ChondroFiller injects a collagen scaffold into focal cartilage lesions—typically grade III–IV defects under 6 cm²—to recruit the patient's progenitor cells for repair rather than replacing tissue artificially.ChondroFiller injects a collagen scaffold into focal cartilage lesions—typically grade III–IV defects under 6 cm²—to recruit the patient's progenitor cells for repair rather than replacing tissue artificially.
ChondroFiller injection versus cartilage surgery
avatar
Miss Sophie Harris
6/8/2026
ChondroFiller injection versus cartilage surgery
ChondroFiller injection achieves 30 IKDC improvement with 3–8% reoperation and 0% complications; microfracture carries 41% reoperation rates with declining long-term outcomes; ACI/MACI matches functional gains but brings 17% complications and 37% reoperation.ChondroFiller injection achieves 30 IKDC improvement with 3–8% reoperation and 0% complications; microfracture carries 41% reoperation rates with declining long-term outcomes; ACI/MACI matches functional gains but brings 17% complications and 37% reoperation.
57 results found in 2ms